CLINICAL_TRIALS
trial_result
· 2025-05-22
Clinical Trial Update: Gastroesophageal Reflux Disease Prospective Registry
Summary
The Gastroesophageal Reflux Disease Prospective Registry (NCT02479438) sponsored by Baylor Research Institute has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Baylor Research Institute | Conditions: GERD | Status: TERMINATED